Journal of Atherosclerosis and Thrombosis

Scope & Guideline

Innovating cardiovascular medicine through impactful research.

Introduction

Immerse yourself in the scholarly insights of Journal of Atherosclerosis and Thrombosis with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1340-3478
PublisherJAPAN ATHEROSCLEROSIS SOC
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 1994 to 1998, from 2000 to 2024
AbbreviationJ ATHEROSCLER THROMB / J. Atheroscler. Thromb.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressNICHINAI-KAIKAN B1, 3-28-8 HONGO BUNKYO-KU, TOKYO 113-0033, JAPAN

Aims and Scopes

The Journal of Atherosclerosis and Thrombosis focuses on providing a comprehensive platform for research related to cardiovascular diseases, particularly those involving atherosclerosis and thrombosis. It aims to advance knowledge in the field through the publication of high-quality studies that explore various aspects of cardiovascular health, risk factors, and treatment strategies.
  1. Atherosclerosis Mechanisms:
    The journal emphasizes research on the biological mechanisms underlying atherosclerosis, including lipid metabolism, inflammation, and plaque formation.
  2. Thrombosis and Vascular Health:
    It covers studies related to thrombotic events, their risk factors, and the impact on vascular health, emphasizing the interplay between thrombosis and atherosclerosis.
  3. Clinical Studies and Trials:
    The journal publishes clinical research, including randomized controlled trials and observational studies, that evaluate the effectiveness of therapeutic interventions for cardiovascular diseases.
  4. Epidemiological Research:
    It includes epidemiological studies that assess the prevalence, risk factors, and outcomes related to cardiovascular diseases, particularly in specific populations.
  5. Innovative Diagnostic and Therapeutic Approaches:
    The journal showcases advancements in diagnostic techniques and therapeutic approaches, including pharmacological and non-pharmacological interventions for managing cardiovascular risk.
The Journal of Atherosclerosis and Thrombosis is witnessing emerging themes that reflect the evolving landscape of cardiovascular research. These trends highlight the importance of personalized medicine, novel therapeutic targets, and the integration of lifestyle factors into cardiovascular health management.
  1. Precision Medicine and Genetic Research:
    There is a growing emphasis on precision medicine, with studies exploring genetic predispositions to cardiovascular diseases and how individualized treatment plans can improve outcomes.
  2. Impact of Lifestyle Factors:
    Research examining the influence of lifestyle factors such as diet, physical activity, and psychosocial elements on cardiovascular health is increasingly prevalent, reflecting a holistic approach to prevention and treatment.
  3. Novel Therapeutic Agents:
    The journal is seeing a rise in studies related to novel therapeutic agents, including PCSK9 inhibitors, SGLT2 inhibitors, and other emerging pharmacological treatments that target specific pathways in atherosclerosis.
  4. Interdisciplinary Approaches:
    Emerging interdisciplinary research that combines cardiology with fields such as endocrinology, nephrology, and nutrition is gaining traction, underscoring the complex nature of cardiovascular health.
  5. Artificial Intelligence and Big Data in Cardiovascular Research:
    The integration of artificial intelligence and big data analytics in cardiovascular research is a rapidly growing area, focusing on predictive modeling and personalized treatment strategies.

Declining or Waning

While the Journal of Atherosclerosis and Thrombosis continues to publish a wide range of studies, some themes appear to be declining in prominence. This can be attributed to shifts in research focus or advancements in understanding that make certain areas less central to current cardiovascular research.
  1. Traditional Lipid Management:
    Research centered solely on traditional lipid management strategies, such as statin therapy, is becoming less frequent as new therapeutic agents and holistic approaches gain attention.
  2. Basic Science of Lipoproteins:
    There is a noticeable decline in studies focused exclusively on the basic science of lipoproteins without clinical applications, as the focus shifts towards translational research that connects laboratory findings to clinical outcomes.
  3. Single-Factor Risk Assessment:
    Research that evaluates cardiovascular risk based on single factors (e.g., cholesterol levels alone) is waning in favor of more comprehensive models that consider multiple risk factors and their interactions.

Similar Journals

JOURNAL OF HUMAN HYPERTENSION

Advancing knowledge on hypertension for a healthier tomorrow.
Publisher: SPRINGERNATUREISSN: 0950-9240Frequency: 12 issues/year

JOURNAL OF HUMAN HYPERTENSION, a prominent publication in the field of internal medicine, is dedicated to advancing the understanding of hypertension and its implications for human health. Published by SPRINGERNATURE in the United Kingdom, this esteemed journal has been a vital resource for researchers and clinicians since its inception in 1987, with a continuous commitment to disseminating high-quality, peer-reviewed research. With an impressive Q2 category rank in Internal Medicine and a Scopus rank of 53 out of 167, it occupies a crucial position within the academic community, reaching a 68th percentile ranking that underscores its significance. The journal aims to provide a platform for innovative studies and reviews, fostering knowledge that bridges basic science, clinical practice, and public health. Although it does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital information about hypertension is available to a broad spectrum of healthcare professionals and researchers. Explore the critical findings and groundbreaking research published in the JOURNAL OF HUMAN HYPERTENSION to stay at the forefront of hypertension studies.

Integrated Blood Pressure Control

Shaping the Future of Cardiovascular Health Together
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7104Frequency: 1 issue/year

Integrated Blood Pressure Control is a distinguished Open Access journal published by DOVE MEDICAL PRESS LTD in New Zealand, dedicated to advancing the field of cardiology and cardiovascular medicine as well as internal medicine. With its established timeline from 2009 to 2024, this journal has earned a commendable Q2 ranking in both its categories for 2023, reflecting its significant contribution to clinical research and practice. With an ISSN of 1178-7104, it provides a platform for high-quality, peer-reviewed articles that address the complexities of blood pressure management, aiming to improve patient outcomes and foster discussions among healthcare professionals. The journal's open-access model, implemented since 2008, ensures that research findings are readily available to all, promoting greater accessibility and dissemination of knowledge in this critical area of health. Researchers, professionals, and students alike are encouraged to engage with the latest findings and innovative practices published within this journal, which plays an essential role in shaping the future of blood pressure control and related medical fields.

Revista de la Federacion Argentina de Cardiologia

Shaping the future of cardiovascular medicine with every publication.
Publisher: FEDERACION ARGENTINA CARDIOLOGIAISSN: 0326-646XFrequency: 4 issues/year

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

CIRCULATION RESEARCH

Elevating knowledge in the dynamic field of cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7330Frequency: 24 issues/year

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

Cardiology in Review

Elevating cardiology through comprehensive scholarship.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1061-5377Frequency: 6 issues/year

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.

CIRCULATION

Driving Discoveries in Cardiovascular Health Since 1950.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

Anatolian Journal of Cardiology

Unlocking the Future of Cardiology Through Open Access Research.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Cardiovascular Diagnosis and Therapy

Transforming Cardiovascular Health with Cutting-Edge Discoveries
Publisher: AME PUBLISHING COMPANYISSN: 2223-3652Frequency: 6 issues/year

Cardiovascular Diagnosis and Therapy, an esteemed journal in the field of Cardiology and Cardiovascular Medicine, is published by AME PUBLISHING COMPANY, based in Hong Kong, China. With an ISSN of 2223-3652 and an E-ISSN of 2223-3660, this open-access journal aims to present cutting-edge research that significantly advances diagnostic and therapeutic practices in cardiovascular health. Recognized for its impact, it holds a 2023 category quartile ranking of Q2 and is positioned at rank #124 out of 387 in Scopus, reflecting its noteworthy contribution to medical literature with a percentile of 68th. The journal welcomes contributions that span various aspects of cardiovascular research, including clinical trials, epidemiological studies, and innovative therapeutic approaches, making it a vital resource for researchers, practitioners, and students alike, committed to improving cardiovascular care.

Artery Research

Fostering collaboration to transform cardiovascular medicine.
Publisher: BMCISSN: 1872-9312Frequency: 4 issues/year

Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.

Current Atherosclerosis Reports

Leading the charge in cardiac research.
Publisher: CURRENT MEDICINE GROUPISSN: 1523-3804Frequency: 12 issues/year

Current Atherosclerosis Reports, published by CURRENT MEDICINE GROUP, is a leading scientific journal in the field of Cardiology and Cardiovascular Medicine, boasting an impressive Q1 ranking in its category as of 2023. This esteemed journal, with an ISSN of 1523-3804 and an E-ISSN of 1534-6242, has been a cornerstone of cardiovascular research since its inception in 1999, continuing to publish cutting-edge studies through 2024. With unparalleled insights into the mechanisms, prevention, and treatment of atherosclerosis, it serves as an essential resource for researchers, healthcare professionals, and students alike. Although not an open-access journal, it is highly regarded within the academic community, highlighted by its Scopus rank of #54 out of 387 in its field, placing it in the 86th percentile. The journal's commitment to advancing knowledge in cardiovascular health underscores its integral role in guiding clinical practices and influencing future research directions.